(Total Views: 46)
Posted On: 08/19/2025 1:45:54 PM
Post# of 389
$ONCY Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
SAN DIEGO, Aug. 11, 2025 /CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"
, a clinical-stage immunotherapy company developing pelareorep, today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Friday, August 8, 2025. A total of 37.42% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting.
https://finance.yahoo.com/news/oncolytics-bio...00517.html
SAN DIEGO, Aug. 11, 2025 /CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"
, a clinical-stage immunotherapy company developing pelareorep, today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Friday, August 8, 2025. A total of 37.42% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting. https://finance.yahoo.com/news/oncolytics-bio...00517.html
(0)
(0)
